1
|
Use of predictive markers of HIV disease progression in vaccine trials.
|
Vaccine
|
2009
|
0.99
|
2
|
Quantitative comparison of carcinogenicity, mutagenicity and electrophilicity of 10 direct-acting alkylating agents and of the initial O6:7-alkylguanine ratio in DNA with carcinogenic potency in rodents.
|
Mutat Res
|
1983
|
0.93
|
3
|
Fighting rabies in Eastern Europe, the Middle East and Central Asia--experts call for a regional initiative for rabies elimination.
|
Zoonoses Public Health
|
2013
|
0.92
|
4
|
Report of the sixth AREB meeting, Manila, The Philippines, 10-12 November 2009.
|
Vaccine
|
2010
|
0.89
|
5
|
[From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].
|
Bull Soc Pathol Exot
|
2006
|
0.83
|
6
|
Considerations of sampling, interactions and IARC evaluations for this group of elements.
|
IARC Sci Publ
|
1986
|
0.75
|
7
|
Antigen content versus volume of rabies vaccines administered intradermally.
|
Biologicals
|
2011
|
0.75
|
8
|
Cytokines in the clinics. Choose your weapon!
|
Eur Cytokine Netw
|
1995
|
0.75
|
9
|
[Current events in vaccination].
|
Med Mal Infect
|
2011
|
0.75
|
10
|
[Update on vaccine research. Proceedings of the 15th annual conference on vaccine research organized by the National Foundation for Infectious Diseases].
|
Arch Pediatr
|
2013
|
0.75
|
11
|
Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
|
IARC Sci Publ
|
1982
|
0.75
|
12
|
[Current events in vaccination].
|
Arch Pediatr
|
2011
|
0.75
|
13
|
Epidemiological studies of passive smoking.
|
IARC Sci Publ
|
1987
|
0.75
|
14
|
Commercial prospects for gene therapy--a company survey.
|
Trends Biotechnol
|
1993
|
0.75
|
15
|
[Awareness and application of vaccine recommendations for chickenpox in French Nurse Schools].
|
Med Mal Infect
|
2007
|
0.75
|
16
|
Industrial perception of EC biotechnology regulations.
|
Trends Biotechnol
|
1994
|
0.75
|